Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ligand Pharmaceuticals to advance Captisol-enabled melphalan program

June 23, 2011

Infinity Pharmaceuticals expands development program for anticancer agent IPI-926

June 23, 2011

Algeta receives grant to develop novel tumor-targeted thorium conjugates

June 23, 2011

Threshold Pharmaceuticals completes enrollment in phase II TH-302 pancreatic cancer trial

June 23, 2011

Jubilant and Endo Pharmaceuticals achieve third milestone in joint oncology program

June 22, 2011

FDA removes clinical hold on SNS01-T IND in multiple myeloma

June 22, 2011

Pfizer discloses phase I data on PF-03084014 and PF-04554878 in solid tumors

June 22, 2011

IBC Generium licenses rights in Russia to Affitech AT-001 antibody

June 22, 2011

Phase I data presented on MLN-9708 in multiple myeloma

June 22, 2011

FDA approves new 6-month formulation of Lupron Depot for advanced prostate cancer

June 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...